|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.55 INR | -1.24% |
|
+7.83% | +55.17% |
| 05-21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| 05-20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.05B 63.63M 54.96M 50.65M 47.41M 88.84M 90.22M 598M 233M 2.94B 239M 234M 10.19B | P/E Ratio 2025 |
32.1x | P/E Ratio 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.91B 72.71M 62.8M 57.87M 54.17M 102M 103M 683M 266M 3.36B 273M 267M 11.65B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.65% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -1.24% | ||
| 1 week | +7.83% | ||
| Current month | +9.01% | ||
| 1 month | +12.79% | ||
| 3 months | +72.95% | ||
| 6 months | +57.02% | ||
| Current year | +55.17% |
| 1 week | 104 |  | 118.55 |
| 1 month | 94.5 | | 118.55 |
| Current year | 59.72 | | 118.55 |
| 1 year | 59.72 | | 126.95 |
| 3 years | 59.72 | | 151.75 |
| 5 years | 27.67 | | 151.75 |
| 10 years | 14 | | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.24% | +7.83% | +5.15% | -2.68% | 63.63M | |
| -0.09% | +0.96% | +7.16% | +82.72% | 45.63B | |
| +0.29% | -3.03% | +41.83% | +84.69% | 33.53B | |
| -0.58% | -0.48% | -9.54% | +38.38% | 11.81B | |
| -1.50% | +0.05% | +11.67% | +98.14% | 11.69B | |
| +4.09% | +0.78% | +36.70% | +129.46% | 9.12B | |
| +0.25% | -1.48% | +19.12% | +42.72% | 7.16B | |
| +2.37% | +0.76% | +45.05% | -15.33% | 6.49B | |
| -0.79% | -0.91% | +28.11% | +235.68% | 6.45B | |
| +0.51% | -3.04% | -43.06% | -3.48% | 5.16B | |
| Average | +0.33% | +0.74% | +14.22% | +69.03% | 13.71B | |
| Weighted average by Cap. | +0.24% | -0.29% | +18.06% | +81.00% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.89M 34.45M 31.75M 29.72M 55.69M 56.55M 375M 146M 1.85B 150M 147M 6.39B | 3.74B 39.39M 34.02M 31.35M 29.35M 54.99M 55.85M 370M 144M 1.82B 148M 145M 6.31B |
| Net income | 122M 1.28M 1.11M 1.02M 953K 1.79M 1.81M 12.03M 4.69M 59.21M 4.8M 4.7M 205M | 58.38M 614K 530K 489K 458K 858K 871K 5.77M 2.25M 28.42M 2.31M 2.26M 98.39M |
| Net Debt | 1.16B 12.18M 10.52M 9.69M 9.07M 17M 17.27M 114M 44.63M 563M 45.71M 44.73M 1.95B | 863M 9.08M 7.84M 7.23M 6.76M 12.68M 12.87M 85.33M 33.27M 420M 34.08M 33.35M 1.45B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-15 | 111.55 ₹ | -1.24% | 6,065 |
| 26-06-12 | 112.95 ₹ | -0.57% | 6,502 |
| 26-06-11 | 113.60 ₹ | +1.97% | 438 |
| 26-06-10 | 111.40 ₹ | +2.58% | 8,721 |
| 26-06-09 | 108.60 ₹ | +4.98% | 575 |
- Stock Market
- Stocks
- 541400 Stock
Select your edition
All financial news and data tailored to specific country editions
